Assessing Co‐Localization of ITM2B With Alzheimer's Disease and Limbic‐Predominant Age‐Related TDP ‐43 Encephalopathy Neuropathologic Changes
Neuropathology · 2025
DOI: 10.1111/neup.70003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropathology, 2025. Verfasst von Ryan K Shahidehpour und 4 weiteren Autor:innen. Beteiligte Einrichtung: Spinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, Kentucky, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, TDP-43 Proteinopathies, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NCRR NIH HHS, NINDS NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Mutations in the Integral membrane protein 2B ( ITM2B ) gene are linked to the development of familial British and Danish dementias, two relatively early‐onset dementia disorders known also to be associated with Tau neurofibrillary tangles (NFTs). However, to date, the involvement of ITM2B in limbic‐predominant age‐related TDP‐43 encephalopathy neuropathologic changes (LATE‐NC) remains unclear. To address this question, we used brain samples from the University of Kentucky Alzheimer's Disease Research Center community‐based autopsy cohort. We investigated the patterns and co‐localizations of ITM2B immunohistochemistry in subiculum, CA1, CA2, CA3 and dentate gyrus of the hippocampus from brains with Alzheimer's disease neuropathologic changes (ADNC), LATE‐NC, and comorbid ADNC+LATE‐NC, as well as low‐pathology controls ( n = 4 per disease state). There was frequent co‐localization between ITM2B protein and intracellular Tau pathology in ADNC; however, there was a far weaker rate of co‐localization between ITM2B and TDP‐43 pathology. There also was, as previously described, an association between ITM2B immunostaining and neuritic‐appearing amyloid plaques. Additionally, co‐localization of intracellular ITM2B pathology with Thioflavin‐S in NFTs suggested a potential role for ITM2B in marking neurons undergoing transition from relatively healthy (early NFT‐bearing cells) to more severely affected (later NFT‐bearing) cellular disease states. This study indicates that ITM2B has a relatively specific pattern of involvement in Tau‐related neurodegeneration and in neuritic amyloid plaques, while implying minimal, if any, role for ITM2B in the synergistic relationship between Tau and TDP‐43 pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Spinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, Kentucky, USA.
- Department of Neuroscience, University of Kentucky, Lexington, Kentucky, USA.
- Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
- Department of Pathology and Laboratory Medicine, Division of Neuropathology, University of Kentucky, Lexington, Kentucky, USA.
ORCID-Profile: Peter T Nelson
Förderung
- NIA NIH HHS
- NCRR NIH HHS
- NINDS NIH HHS
Zitieren
APA
Shahidehpour, R. K., Nelson, P. T., Srinivasan, S., Yu, Z., & Bachstetter, A. D. (2025). Assessing Co‐Localization of ITM2B With Alzheimer's Disease and Limbic‐Predominant Age‐Related TDP ‐43 Encephalopathy Neuropathologic Changes. Neuropathology. https://doi.org/10.1111/neup.70003
Vancouver
Shahidehpour RK, Nelson PT, Srinivasan S, Yu Z, Bachstetter AD. Assessing Co‐Localization of ITM2B With Alzheimer's Disease and Limbic‐Predominant Age‐Related TDP ‐43 Encephalopathy Neuropathologic Changes. Neuropathology. 2025. doi:10.1111/neup.70003
BibTeX
@article{Shahidehpour2025,
author = {Shahidehpour, Ryan K and Nelson, Peter T and Srinivasan, Sukanya and Yu, Zhong and Bachstetter, Adam D},
title = {Assessing Co‐Localization of ITM2B With Alzheimer's Disease and Limbic‐Predominant Age‐Related TDP ‐43 Encephalopathy Neuropathologic Changes},
journal = {Neuropathology},
year = {2025},
doi = {10.1111/neup.70003}
}
EUVIMED